Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
World J Gastroenterol ; 21(19): 5950-60, 2015 May 21.
Article in English | MEDLINE | ID: mdl-26019460

ABSTRACT

AIM: To determine the efficacy and safety of meticulous cannulation by needle-knife. METHODS: Three needle-knife procedures were used to facilitate cannulation in cases when standard cannulation techniques failed. A total of 104 cannulations via the minor papilla attempted in 74 patients at our center between January 2008 and June 2014 were retrospectively reviewed. RESULTS: Standard methods were successful in 79 cannulations. Of the 25 cannulations that could not be performed by standard methods, 19 were performed by needle-knife, while 17 (89.5%) were successful. Needle-knife use improved the success rate of cannulation [76.0%, 79/104 vs 92.3%, (79 + 17)/104; P = 0.001]. When the 6 cases not appropriate for needle-knife cannulation were excluded, the success rate was improved further (80.6%, 79/98 vs 98.0%, 96/98; P = 0.000). There were no significant differences in the rates of post-endoscopic retrograde cholangiopancreatography adverse events between the group using standard methods alone and the group using needle-knife after failure of standard methods (4.7% vs 10.5%, P = 0.301). CONCLUSION: The needle-knife procedure may be an alternative method for improving the success rate of cannulation via the minor papilla, particularly when standard cannulation has failed.


Subject(s)
Catheterization/methods , Cholangiopancreatography, Endoscopic Retrograde/methods , Pancreatic Diseases/surgery , Pancreatic Ducts/surgery , Sphincterotomy, Endoscopic/methods , Adolescent , Adult , Catheterization/adverse effects , Child , Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Female , Humans , Male , Pancreatic Diseases/diagnosis , Pancreatic Ducts/diagnostic imaging , Pancreatic Ducts/pathology , Postoperative Complications/etiology , Predictive Value of Tests , Retrospective Studies , Sphincterotomy, Endoscopic/adverse effects , Time Factors , Treatment Outcome
2.
Mol Med Rep ; 7(3): 959-64, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23338621

ABSTRACT

Hemangiopoietin (HAPO) is a novel growth factor stimulating the proliferation of hematopoietic and endothelial progenitor cells in vitro and in vivo. The native protein is a 294­amino acid multimodular protein. The N­terminus constitutes of two somatomedin B (SMB) homology domains that contain 14 cysteines. The central region is a putative heparin­binding domain (pHBD) and the C­terminus contains mucin­like repeats. In the present study, we demonstrated that prokaryotic recombinant human HAPO (rhHAPO) self­associates into a multimeric form with a mass weight of ~129 kDa, suggesting a homologous tetramer. rhHAPO in its multimeric form was found to be more stable and more potent in promoting HESS­5 cell adhesion. Multimeric rhHAPO had a higher affinity to heparin compared with its dimeric form, although there was no significant conformational change. C­terminal repeats-truncated rhHAPO (rhHAPOΔmucin) was also found to be assembled into a multimer, while deletion of pHBD (rhHAPOΔmucin­pHBD) caused the protein to remain in a dimeric form, demonstrating that SMB domains participate in self­aggregation of the molecule and that the pHBD region promotes the tetramerization.


Subject(s)
Heparin/metabolism , Proteoglycans/metabolism , Cell Adhesion/drug effects , Circular Dichroism , Dimerization , Humans , Protein Binding , Protein Multimerization , Protein Structure, Tertiary , Proteoglycans/chemistry , Proteoglycans/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...